Latest LRRK2 Stories
PPMI now recruiting individuals with genetic mutation linked to Gaucher disease NEW YORK, March 24, 2015 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI),
NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease.
Biomedical research institute appoints two key positions, expanding its impact on neurodegenerative science GRAND RAPIDS, Mich., March 26, 2014 /PRNewswire/ --
NEW YORK, Feb. 25, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J.
The most devastating aspect of Parkinson's disease may not be its debilitating symptoms, which rob its victims of their ability to control their own movement.
- A person in a secondary role, specifically the second most important character (after the protagonist).